top of page
Insights for Life Sciences Talent Leaders
Strategic guidance on life sciences executive recruitment and human capital for search partners, biotech innovators, and scale-up HR leaders. I also share occasional personal reflections on the industry.


GLP-1s Beyond Obesity: What the Evidence Really Shows
GLP‑1 medicines have moved from metabolic workhorses to front-page news. Originally designed for diabetes, they now sit at the centre of conversations about obesity, cardiovascular risk – and increasingly, brain and cancer biology.
Beneath the headlines, two distinct questions are emerging for R&D and portfolio leaders:
In neurodegeneration, are GLP‑1s genuinely touching disease mechanisms in Alzheimer’s and Parkinson’s, or are they mainly cleaning up upstream metabolic and
sharonshieldsconsu
Sep 283 min read


AI in Pharma: Bridging Research and Real-World Experience
If you read recent scientific reviews on artificial intelligence (AI) in the pharmaceutical industry, you get a clear message: AI is transforming drug discovery, clinical development, manufacturing, and safety.¹⁻⁵ However, if you talk to bench scientists, clinical teams, or data scientists over coffee, you often hear a more complicated story: pockets of impressive success, a lot of incremental improvements, and quite a few stalled pilots. Both perspectives are true. They’re j
sharonshieldsconsu
Jul 239 min read


Location, Location, Location - Where to set up your Biopharma or Therapeutics business in Europe?
Choosing where to set up in Europe is just the beginning. The real challenge — and the real competitive advantage — lies in finding, attracting, and retaining the right people in markets where the best talent has choices
sharonshieldsconsu
Jul 1713 min read


For Decades, Collateral Damage Was the Price of Cancer Treatment. That’s Finally Changing.
For Decades, Collateral Damage Was the Price of Cancer Treatment. That’s Finally Changing.
sharonshieldsconsu
Jul 143 min read
bottom of page